Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy from Sub-Saharan Africa, Europe, and Asia

J. Bohlius, Antonella Castagna

Research output: Contribution to journalArticlepeer-review

Abstract

Background. The burden of Kaposi sarcoma (KS) in human immunodeficiency virus (HIV)-infected children and adolescents on combination antiretroviral therapy (cART) has not been compared globally. Methods. We analyzed cohort data from the International Epidemiologic Databases to Evaluate AIDS and the Collaboration of Observational HIV Epidemiological Research in Europe. We included HIV-infected children aged
Original languageEnglish
Pages (from-to)1245 - 1253
Number of pages9
JournalClinical Infectious Diseases
Volume63
Issue number9
DOIs
Publication statusPublished - Nov 1 2016

Keywords

  • antiretroviral therapy
  • children
  • cohort study
  • HIV
  • Kaposi sarcoma

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy from Sub-Saharan Africa, Europe, and Asia'. Together they form a unique fingerprint.

Cite this